Your browser doesn't support javascript.
loading
Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.
Cho, Hee Jin; Zhao, Junfei; Jung, Sang Won; Ladewig, Erik; Kong, Doo-Sik; Suh, Yeon-Lim; Lee, Yeri; Kim, Donggeon; Ahn, Sun Hee; Bordyuh, Mykola; Kang, Hyun Ju; Sa, Jason K; Seo, Yun Jee; Kim, Sung Tae; Lim, Do Hoon; Dho, Yun-Sik; Lee, Jung-Il; Seol, Ho Jun; Choi, Jung Won; Park, Woong-Yang; Park, Chul-Kee; Rabadan, Raul; Nam, Do-Hyun.
Afiliação
  • Cho HJ; Institute for Refractory Cancer Research, Seoul, Korea.
  • Zhao J; Research Institute for Future Medicine, Seoul, Korea.
  • Jung SW; Department of Systems Biology, Columbia University, New York, New York, USA.
  • Ladewig E; Department of Biomedical Informatics, Columbia University, New York, New York, USA.
  • Kong DS; Institute for Refractory Cancer Research, Seoul, Korea.
  • Suh YL; Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.
  • Lee Y; Department of Systems Biology, Columbia University, New York, New York, USA.
  • Kim D; Department of Biomedical Informatics, Columbia University, New York, New York, USA.
  • Ahn SH; Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Bordyuh M; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kang HJ; Institute for Refractory Cancer Research, Seoul, Korea.
  • Sa JK; Research Institute for Future Medicine, Seoul, Korea.
  • Seo YJ; Institute for Refractory Cancer Research, Seoul, Korea.
  • Kim ST; Research Institute for Future Medicine, Seoul, Korea.
  • Lim DH; Institute for Refractory Cancer Research, Seoul, Korea.
  • Dho YS; Department of Systems Biology, Columbia University, New York, New York, USA.
  • Lee JI; Department of Biomedical Informatics, Columbia University, New York, New York, USA.
  • Seol HJ; Institute for Refractory Cancer Research, Seoul, Korea.
  • Choi JW; Research Institute for Future Medicine, Seoul, Korea.
  • Park WY; Institute for Refractory Cancer Research, Seoul, Korea.
  • Park CK; Research Institute for Future Medicine, Seoul, Korea.
  • Rabadan R; Institute for Refractory Cancer Research, Seoul, Korea.
  • Nam DH; Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Neuro Oncol ; 21(1): 47-58, 2019 01 01.
Article em En | MEDLINE | ID: mdl-30085274
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Neoplasias Cerebelares / Glioblastoma / Genômica / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Transcriptoma Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Regulação Neoplásica da Expressão Gênica / Neoplasias Cerebelares / Glioblastoma / Genômica / Inibidores de Proteínas Quinases / Terapia de Alvo Molecular / Transcriptoma Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Neuro Oncol Assunto da revista: NEOPLASIAS / NEUROLOGIA Ano de publicação: 2019 Tipo de documento: Article